Long-term supply. 17.1.1 Supplier shall supply Goods corresponding exactly to the technical specifications as set out in the Contract, for a period of thirty (30) years unless otherwise agreed in the Contract, as from the delivery date of the last series equipment of the last order linked to a same Project.
Long-term supply. 17.6.1. The Supplier shall ensure that the Goods, as well as their parts, components and Spare Parts (as the casemaybe), willremainavailableandinfullcompliancewiththeTechnicalSpecificationsforaperiodofthirty- five (35) years from the date of delivery of the last Goods with respect to a same project. The Supplier shall provide supply, repair, testor supportofany Goods, or Spare Parts thereof, during this period of thirty-five (35) years.
Long-term supply. To assist with Monsanto’s decision to exercise the License Purchase Option, the Parties will use good faith efforts to negotiate and agree upon the margin over Purchase Price that Monsanto will pay Landec to manufacture and supply Polymer to Monsanto pursuant to the supply agreement that the Parties will negotiate and enter into pursuant to Section 3.4.2 below if Monsanto exercises the License Purchase Option.
Long-term supply. Supplier will provide the Goods and Services, replacement parts, repair services and technical support at reasonable and competitive pricing for at least 10 years after the last Order. Supplier will keep all major spare parts on stock, ready for immediate dispatch to the site.
Long-term supply. (i) Immediately following the Effective Date, Durect and King agree to create a joint team consisting of three people from the technical operations group of each Party, and the Parties shall, through such joint team, establish key terms acceptable to both Parties relating to the long-term supply by [ * * *] of pharmaceutical grade [ * * *] Starter Materials (the “Agreed [ * * *] LTSA Terms”).
Long-term supply. In addition to the supply commitment set forth in Section 3(c) above, Genentech shall supply Altus with Compound which, as of the Termination Date, is [*****] by Genentech, pursuant to a written supply agreement, for each of the Option and Licensed Territories as follows:
Long-term supply. Subject to early termination of this Agreement in accordance with the provisions of Section 7.2 hereof, Draxis shall Formulate the Product for Bone Care for the duration of this Agreement.
